Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

IQVIA Holdings Inc.

NYSE

Market Cap.

41.83B

Avg. Volume

859.01K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze IQVIA Holdings Inc.!

Still processing it, give me a bit more time...

IQVIA Holdings Inc. News

IQVIA Holdings Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Diagnostics & Research
iqvia.com

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

IQVIA Holdings Inc. Earnings & Revenue

IQVIA Holdings Inc. Financials

Table Compare

Compare IQV metrics with:

   

Earnings & Growth

IQV

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

IQV

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

IQV

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

IQV

None

Debt Ratio

--

--

Quick Ratio

--

--

 

IQVIA Holdings Inc. Income

IQVIA Holdings Inc. Balance Sheet

IQVIA Holdings Inc. Cash Flow

IQVIA Holdings Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

IQVIA Holdings Inc. Executives

NameRole
Mr. Ari BousbibChief Executive Officer & Chairman
Mr. Ronald E. BruehlmanExecutive Vice President & Chief Financial Officer
Mr. Eric M. SherbetExecutive Vice President, General Counsel & Secretary
Mr. W. Richard Staub IIIPresident of Research & Development Solutions
Dr. Jeffrey A. Spaeder M.D.Senior Vice President, Global Chief Medical & Scientific Officer
NameRoleGenderDate of BirthPay
Mr. Ari BousbibChief Executive Officer & ChairmanMale19617.15M
Mr. Ronald E. BruehlmanExecutive Vice President & Chief Financial OfficerMale19612.14M
Mr. Eric M. SherbetExecutive Vice President, General Counsel & SecretaryMale19641.37M
Mr. W. Richard Staub IIIPresident of Research & Development SolutionsMale1963886.44K
Dr. Jeffrey A. Spaeder M.D.Senior Vice President, Global Chief Medical & Scientific Officer

--

IQVIA Holdings Inc. Insider Trades

Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares0
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares2549
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares1740
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares5150
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares6906
DateNameRoleTransactionTypeShares
7 MayPatel BhavikSee RemarksDisposed0
7 MayPatel BhavikSee RemarksDisposed2549
7 MayPatel BhavikSee RemarksDisposed1740
7 MayPatel BhavikSee RemarksDisposed5150
7 MayPatel BhavikSee RemarksDisposed6906

Discover More

Streamlined Academy

IQVIA Holdings Inc.

NYSE

Market Cap.

41.83B

Avg. Volume

859.01K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

IQVIA Holdings Inc. News

IQVIA Holdings Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

IQVIA Holdings Inc. Earnings & Revenue

IQVIA Holdings Inc. Income

IQVIA Holdings Inc. Balance Sheet

IQVIA Holdings Inc. Cash Flow

IQVIA Holdings Inc. Financials Over Time

IQVIA Holdings Inc. Executives

NameRole
Mr. Ari BousbibChief Executive Officer & Chairman
Mr. Ronald E. BruehlmanExecutive Vice President & Chief Financial Officer
Mr. Eric M. SherbetExecutive Vice President, General Counsel & Secretary
Mr. W. Richard Staub IIIPresident of Research & Development Solutions
Dr. Jeffrey A. Spaeder M.D.Senior Vice President, Global Chief Medical & Scientific Officer
NameRoleGenderDate of BirthPay
Mr. Ari BousbibChief Executive Officer & ChairmanMale19617.15M
Mr. Ronald E. BruehlmanExecutive Vice President & Chief Financial OfficerMale19612.14M
Mr. Eric M. SherbetExecutive Vice President, General Counsel & SecretaryMale19641.37M
Mr. W. Richard Staub IIIPresident of Research & Development SolutionsMale1963886.44K
Dr. Jeffrey A. Spaeder M.D.Senior Vice President, Global Chief Medical & Scientific Officer

--

IQVIA Holdings Inc. Insider Trades

Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares0
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares2549
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares1740
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares5150
Date7 May
NamePatel Bhavik
RoleSee Remarks
TransactionDisposed
Type
Shares6906
DateNameRoleTransactionTypeShares
7 MayPatel BhavikSee RemarksDisposed0
7 MayPatel BhavikSee RemarksDisposed2549
7 MayPatel BhavikSee RemarksDisposed1740
7 MayPatel BhavikSee RemarksDisposed5150
7 MayPatel BhavikSee RemarksDisposed6906

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
iqvia.com

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze IQVIA Holdings Inc.!

Still processing it, give me a bit more time...

IQVIA Holdings Inc. Financials

Table Compare

Compare IQV metrics with:

   

Earnings & Growth

IQV

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

IQV

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

IQV

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

IQV

None

Debt Ratio

--

--

Quick Ratio

--

--

 

IQVIA Holdings Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More